Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT04870346

Long Term Follow-up Observational Study After Clinical Trials of AMG531 (Romiplostim) in Patients With Untreated Aplastic Anemia

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
36 (actual)
Sponsor
Kyowa Kirin Co., Ltd. · Industry
Sex
All
Age
Healthy volunteers

Summary

To evaluate the long-term efficacy and safety after the end of romiplostim treatment by observation \[up to 5 years\] of patients who were registered for Study 531-003/531-004 in immunosuppressive therapy-naïve patients with aplastic anemia.

Conditions

Timeline

Start date
2021-05-10
Primary completion
2024-08-31
Completion
2027-06-30
First posted
2021-05-03
Last updated
2025-09-11

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT04870346. Inclusion in this directory is not an endorsement.

Long Term Follow-up Observational Study After Clinical Trials of AMG531 (Romiplostim) in Patients With Untreated Aplasti (NCT04870346) · Clinical Trials Directory